Parkwood LLC’s MacroGenics MGNX Stock Holding History

Parkwood LLC’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,280	Closed	-$446K	–	126
2021 Q3	$446K	Buy	21,280 +6,477	+44%	+$156K	0.05%	105
2021 Q2	$398K	Buy	+14,803	New	+$434K	0.05%	112

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parkwood LLC's MGNX Position: Q4 2021 in Review

Parkwood LLC sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 21,280 shares — an estimated $446K sold.

Parkwood LLC first reported a position in MGNX in Q2 2021 and held it in 2 quarters. The position peaked at $446K in Q3 2021. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

Parkwood LLC reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
Parkwood LLC sold 21,280 MacroGenics shares in Q4 2021, an estimated $446K.
Parkwood LLC first reported a position in MacroGenics in Q2 2021 and held it in 2 quarters.
Parkwood LLC's MacroGenics position peaked at $446K in Q3 2021.
156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Parkwood LLC's 13F filing for Q4 2021, filed 11 Feb 2022.